Let's say someone wanted to make an RNA library (for the MiSeq or HiSeq) without using RNA-Seq. Is it valid to just remove the ribosomal RNA, make cDNA, and then make a TruSeq library? Would you use the same shearing protocol on the Covaris that you do for genomic DNA even though it's already in smaller pieces?
-
-
It is a valid way to make a library-especially if you do not have sufficent RNA to put into a protocol. The only disadvatage is that you lose stranded-ness.
Yes-I run the same Covaris program for cDNA and DNA. -
Basically, there's no difference at all between an RNASeq library and a transcriptome library, the difference in the two terms is really about how you treat your data. If you need to assemble the data for de novo transcriptome analysis, which it seems you might be doing, you'll want the library to be strand specific as it will greatly aid in assembly.
Aside form that, there's no difference in making a transcriptome library from rRNA depleted cDNA compared to a standard DNA library. Depending on what you're doing, and assuming you use the HiSeq, you may not even need to remove the rRNAs. And depending on which system you do sequence one, you may want to adjust your shearing to give you the best fragment size for the sequencing kit you'll be using (e.g. 750bp fragments for a 600 cycle V3 MiSeq kit versus 4-500 bp for a HiSeq run).Comment
-
Essentially this is how some of the libraries were a few years ago...cDNA conversion frist then shearing. It should be noted however, that it was also shown that there is some biases introduced by shearing after making cDNA compared to shearing the RNA first.Comment
-
Halfway in, I've realized that cDNA is single-stranded. Does end-repair, a-tailing, and ligating on adapters work on single stranded DNA? Ackkkkk!Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment